May FDA panel to discuss Ebola vax development; U.S., Indian scientists debate swine flu strain's virulence;

> An FDA panel will discuss Ebola vaccine development on May 12. Report

> Scientists in the U.S. and India are battling over the virulence of the latter country's swine flu strain. More

> Immunovaccine is seeking approval to have its common shares trade on the OTCQX(R) Best Marketplace. Release

> NIH's National Institute of Allergy and Infectious Diseases (NIAID) has awarded $16 million to a University of Pennsylvania-led group to develop synthetic DNA vaccines to fight HIV. More

> A new vaccine from China's Yisheng Biopharma for post-exposure treatment of rabies infection has entered human clinical trials. Report

And Finally... India's government is launching a 15-day media campaign to educate the masses on immunization. More

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.